Satake, D.; Natsumeda, M.; Satomi, K.; Tada, M.; Sato, T.; Okubo, N.; Kawabe, K.; Takahashi, H.; Tsukamoto, Y.; Okada, M.; Sano, M.; Iwabuchi, H.; Shibata, N.; Imamura, M.; Imai, C.; Takami, H.; Ichimura, K.; Nishikawa, R.; Umezu, H.; Kakita, A.; Oishi, M. Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant Features. Curr. Oncol.2024, 31, 1831-1838.
Satake, D.; Natsumeda, M.; Satomi, K.; Tada, M.; Sato, T.; Okubo, N.; Kawabe, K.; Takahashi, H.; Tsukamoto, Y.; Okada, M.; Sano, M.; Iwabuchi, H.; Shibata, N.; Imamura, M.; Imai, C.; Takami, H.; Ichimura, K.; Nishikawa, R.; Umezu, H.; Kakita, A.; Oishi, M. Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant Features. Curr. Oncol. 2024, 31, 1831-1838.
Satake, D.; Natsumeda, M.; Satomi, K.; Tada, M.; Sato, T.; Okubo, N.; Kawabe, K.; Takahashi, H.; Tsukamoto, Y.; Okada, M.; Sano, M.; Iwabuchi, H.; Shibata, N.; Imamura, M.; Imai, C.; Takami, H.; Ichimura, K.; Nishikawa, R.; Umezu, H.; Kakita, A.; Oishi, M. Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant Features. Curr. Oncol.2024, 31, 1831-1838.
Satake, D.; Natsumeda, M.; Satomi, K.; Tada, M.; Sato, T.; Okubo, N.; Kawabe, K.; Takahashi, H.; Tsukamoto, Y.; Okada, M.; Sano, M.; Iwabuchi, H.; Shibata, N.; Imamura, M.; Imai, C.; Takami, H.; Ichimura, K.; Nishikawa, R.; Umezu, H.; Kakita, A.; Oishi, M. Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant Features. Curr. Oncol. 2024, 31, 1831-1838.
Abstract
Molecular analysis of growing teratoma syndrome has not been extensively studied. Here, we report a 14-year-old boy with a growing mass during treatment for a mixed germ cell tumor of the pineal region. Tumor markers were negative; thus, growing teratoma syndrome was suspected. A radical resection via the occipital transtentorial approach was performed, and histopathological examination revealed a teratoma with malignant features. Methylation classifier analysis confirmed the diagnosis of teratoma, and DMRT1 loss and 12p gain were identified by copy number variation analysis, potentially elucidating the cause of growth and malignant transformation of the teratoma. The patient remains in remission after intense chemoradiation treatment as a high-risk germ cell tumor.
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.